Corindus Vascular Robotics (CVRS) Reports In-Line Q4 EPS

Go back to Corindus Vascular Robotics (CVRS) Reports In-Line Q4 EPS

Corindus Vascular Robotics (CVRS) PT Raised to $2 at Ladenburg Thalmann

March 13, 2019 9:18 AM UTC

Ladenburg Thalmann analyst Jeffrey Cohen raised the price target on Corindus Vascular Robotics (NYSE: CVRS) to $2.00 (from $1.70) while maintaining a Buy rating following the company's 4Q. Revenue, net loss, and loss per share for the quarter was $4.7 million, $7.4 million, and $0.04. Consensus estimate for the quarter were... More